Clinipace Selects TransPerfect’s Trial Interactive E-Feasibility and eTMF Solutions to Support Future Studies
Summary
NEW YORK--(BUSINESS WIRE)--TransPerfect Life Sciences, a leading provider of technologies and services to support clinical trials and product development for the biopharmaceutical industry, today announced that Clinipace has selected TransPerfect’s Trial Interactive E-Feasibility and eTMF solutions as part of their ongoing initiative to further cultivate a flexible and responsive infrastructure to support clinical research. Investments in innovative technologies enable Clinipace to provide industry-leading tools to staff, site personnel, and clients with maximum transparency and visibility. “We reviewed many solutions, and Trial Interactive offered the intuitive interface, transparency, hosting, support, and validation that was essential to our decision,” said Michael Townley, CIO, Clinipace. “The additional willingness to work with our other vendors and integration partners made Trial Interactive an obvious choice.” “We are proud to have been selected by Clinipace to add our E-Feasibility and eTMF solutions to their technology stack,” said Phil Shawe, President and CEO of TransPerfect. We strive to improve the way clinical research is performed and impact the future of health care using the most advanced technology and a CHALLENGE ACCEPTED approach.
Classifications
AskAI Classifications
LabelsLinked Companies
